Trump Pharma Plan Looks Like Reprieve for Many Drugmakers
NeutralTechnology

President Trump's recent proposal to impose a 100% tariff on branded drug imports has sparked a mixed reaction among investors. While some are concerned about the potential impact on drug prices, many believe that the exemptions for companies manufacturing in the U.S. will mitigate the effects. This plan is significant as it highlights the ongoing debate over drug pricing and the balance between protecting domestic industries and ensuring affordable healthcare.
— Curated by the World Pulse Now AI Editorial System